Skip to main content
. 2014 Jan 28;22(4):854–861. doi: 10.1038/mt.2013.276

Figure 6.

Figure 6

Semiquantitative studies of survival motor neuron (SMN) protein detected upon antisense oligonucleotide (AON) treatment. (a) For each AON transfection, duplicates of western blot analyses were performed. The mean fold increase of SMN protein from induced by each AON treatment is relative to Lipofectamine2000 only treatment (denoted as NT). (b) Fold increase of full-length SMN transcripts (from Figures 3 and 4) superimposed with fold increase of full-length SMN protein (from Figure 6a) at 100 nmol/l or 200 nmol/l of AON dosage.